Victor Fabano
Chief Operating Officer at OSPY MEDI CDI
Profile
Victor Fabano is currently working as the Vice President of Operations & Information Technology at Osprey Medical, Inc. He started this position in 2018.
Prior to his current role, he worked as the Vice President of Operations & Quality at Anulex Technologies, Inc. from 2008 to 2012.
Mr. Fabano completed his undergraduate degree at the University of North Dakota.
Victor Fabano active positions
Companies | Position | Start |
---|---|---|
OSPY MEDI CDI | Chief Operating Officer | 2012-05-31 |
Former positions of Victor Fabano
Companies | Position | End |
---|---|---|
Anulex Technologies, Inc.
Anulex Technologies, Inc. Medical SpecialtiesHealth Technology Anulex Technologies, Inc. develops medical technologies. It focuses on the research and development of medical technologies to preserve and repair soft tissue of the spine for patients undergoing a surgical procedure to remove a herniated disc. The company was founded in 2001 by Matthew M. Burns and is headquartered in Minneapolis, MN. | Chief Operating Officer | 2011-12-31 |
Training of Victor Fabano
University of North Dakota | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Anulex Technologies, Inc.
Anulex Technologies, Inc. Medical SpecialtiesHealth Technology Anulex Technologies, Inc. develops medical technologies. It focuses on the research and development of medical technologies to preserve and repair soft tissue of the spine for patients undergoing a surgical procedure to remove a herniated disc. The company was founded in 2001 by Matthew M. Burns and is headquartered in Minneapolis, MN. | Health Technology |
Osprey Medical, Inc.
Osprey Medical, Inc. Medical SpecialtiesHealth Technology Osprey Medical, Inc. engages in the development to prevent harmful effect of x-ray dye used during angiographic imaging procedures. Its product includes Dyevert system, which is designed to reduce the amount of dye contrast injected into the patients during standard cardiovascular procedures. The company was founded by Frank Solomon, David Kaye, and James Edward Shapland on August 31, 2005 and is headquartered in Minnetonka, MN. | Health Technology |
- Stock Market
- Insiders
- Victor Fabano